The US health regulator is delaying a decision on authorizing Moderna Inc's COVID-19 vaccine for adolescents to assess whether the shot may lead to heightened risk of heart inflammation, the Wall Street Journal reported on Friday, citing people familiar with the matter.
US FDA delays decision on Moderna's COVID-19 vaccine for adolescents
By REUTERS
11/14/2024 01:19 AM
By REUTERS
11/14/2024 01:17 AM
By REUTERS
11/14/2024 01:13 AM
By REUTERS
11/13/2024 11:12 PM
By REUTERS
11/13/2024 10:24 PM
By WALLA! CULTURE
11/13/2024 09:08 PM
By REUTERS
11/13/2024 07:27 PM